The Fibrosis-Targeted Collagen/Integrins Gene Profile Predicts Risk of Metastasis in Pulmonary Neuroendocrine Neoplasms

Nenhuma Miniatura disponível

Data

2021-08-11

Autores

Prieto, Tabatha Gutierrez
Machado-Rugolo, Juliana [UNESP]
Baldavira, Camila Machado
Velosa, Ana Paula Pereira
Teodoro, Walcy Rosolia
Saber, Alexandre Muxfeldt Ab´
Capelozzi, Vera Luiza

Título da Revista

ISSN da Revista

Título de Volume

Editor

Resumo

Recently, collagen/integrin genes have shown promise as predictors of metastasis mainly in non-small cell lung cancer and breast cancer. However, it is unknown if these gene expression profiling differ in metastatic potential of pulmonary neuroendocrine neoplasms (PNENs). In this study, we sought to identify differentially expressed collagen/integrin genes in PNENs in order to understand the molecular mechanisms underlying the development of stroma-associated fibrosis for invasion and metastasis. We compared collagen/integrin gene expression profiling between PNE tumors (PNETs) and PNE carcinomas (PNECs) using a two-stage design. First, we used PCR Array System for 84 ECM-related genes, and among them, we found COL1A2, COL3A1, COL5A2, ITGA5, ITGAV, and ITGB1 functionally involved in the formation of the stroma-associated fibrosis among PNENs histological subtypes. Second, we examined the clinical association between the six collagen/integrin genes in tumor tissues from 24 patients with surgically excised PNENs. However, the pathological exam of their resected tissues demonstrated that 10 developed lymph node metastasis and 7 distant metastasis. We demonstrated and validated up regulation of the six fibrogenic genes in PNECs and down regulation in PNETs that were significantly associated with metastasis-free and overall survival (P<0.05). Our study implicates up regulation of fibrogenic genes as a critical molecular event leading to lymph node and distant metastasis in PNENs.

Descrição

Palavras-chave

collagens, extracellular matrix, integrins, metastasis, pulmonary neuroendocrine neoplasms, surgical resection

Como citar

Frontiers in Oncology, v. 11.